July 5, 2011
Dear Friends,
I’m sending this letter to let you know I will be ending my work as the HD Research Coordinator on July 31, 2011. It has been a rewarding 27 years working with you and your families. You have taught me so much as you shared your lives with me. I will remember you always for the wonderful folks you are and the dedication you and your families have given to help fight this disease.
This is a good time for me to move on as the Pharos, Predict and Cohort studies have now ended. Enroll-HD (the continuation of Cohort) will commence this fall, and you will be contacted by my replacement to ask if you will continue.
Carol Pantella will be continuing with her HD Drug Study Research (2-CARE) so she will always be a good resource person for you.
I am continuing my interest in genetic research at the U of C, but with another investigator in another field.
I leave you with a heavy heart, but with many good memories. I wish you well, my friends. I hope our paths will continue to cross.
With many thanks,
Sincerely,
Mary Lou Nicolson Klimek
Filed under: clinical trials Tagged: | 2-Care, Carol Pantella, Cohort, Enroll-HD, genetic research, HD Research Coordinator, Huntington disease, Huntington Study Group, Mary Lou Nicolson Klimek, Pharos, Predict, University of Calgary, volunteer
